Aadi Bioscience, Inc.
Clinical trials sponsored by Aadi Bioscience, Inc., explained in plain language.
-
New drug combo tested for Tough-to-Treat uterine cancer
Disease control Recruiting nowThis study is testing whether combining two drugs, nab-sirolimus (given by IV) and letrozole (a daily pill), can help control advanced or recurrent endometrial cancer. It is for patients whose cancer has returned or spread and who have had zero to one prior rounds of chemotherapy…
Phase: PHASE2 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Early cancer drug trial focuses on patients with compromised livers
Disease control Recruiting nowThis early-stage study aims to find a safe dose of the drug nab-sirolimus for adults with advanced solid tumors who also have moderate liver problems. It will compare how the drug is processed in the body between these patients and those with normal liver function. The main goal …
Phase: PHASE1 • Sponsor: Aadi Bioscience, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC